Valuation: Zoetis Inc.

Capitalization 78.45B 75.76B 71.72B 63.21B 112B 6,818B 125B 856B 316B 2,833B 294B 288B 12,142B P/E ratio 2024 *
32x
P/E ratio 2025 * 29x
Enterprise value 82.83B 79.99B 75.72B 66.74B 119B 7,198B 132B 904B 334B 2,991B 311B 304B 12,820B EV / Sales 2024 *
8.95x
EV / Sales 2025 * 8.61x
Free-Float
89.78%
Yield 2024 *
0.99%
Yield 2025 * 1.13%
More valuation ratios * Estimated data
Dynamic Chart
1 day-7.06%
1 week-1.02%
Current month+1.74%
1 month+6.47%
3 months-0.05%
6 months-5.40%
Current year+6.72%
More quotes
1 week
170.52
Extreme 170.52
175.50
1 month
161.58
Extreme 161.58
177.40
Current year
160.59
Extreme 160.59
177.40
1 year
144.80
Extreme 144.8
200.53
3 years
124.15
Extreme 124.1483
201.92
5 years
90.14
Extreme 90.14
249.27
10 years
37.73
Extreme 37.73
249.27
More quotes
Director TitleAgeSince
Chief Executive Officer 53 2019-12-31
Director of Finance/CFO 53 2021-05-31
Chief Tech/Sci/R&D Officer - 2023-02-28
Manager TitleAgeSince
Chairman 67 2012-06-30
Director/Board Member 67 2012-12-31
Chairman 72 2013-06-25
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.24%-1.02%-11.60%-12.57% 78.45B
-0.26%-5.40% - - 5.63B
-1.80%-0.17%+40.94%-6.16% 4.19B
-0.48%-1.74%-8.39%-6.89% 2.71B
+12.99%+11.58%+48.44%-19.50% 1.9B
+0.06%-5.11%+6.37%-24.35% 1.04B
-5.82%+9.97%+102.14%+17.03% 996M
-0.03%-.--%+67.19%+66.38% 919M
-0.31%+0.78%-30.31%-50.46% 903M
+0.54%+0.27%-27.69%-38.31% 901M
Average -0.22%+0.32%+20.79%-8.31% 9.76B
Weighted average by Cap. -5.58%-1.07%-5.99%-11.90%
See all sector performances

Financials

2024 *2025 *
Net sales 9.25B 8.94B 8.46B 7.45B 13.24B 804B 14.77B 101B 37.27B 334B 34.69B 33.99B 1,432B 9.57B 9.24B 8.74B 7.71B 13.69B 831B 15.27B 104B 38.53B 345B 35.86B 35.14B 1,481B
Net income 2.49B 2.4B 2.27B 2B 3.56B 216B 3.97B 27.16B 10.02B 89.86B 9.33B 9.14B 385B 2.7B 2.61B 2.47B 2.18B 3.86B 235B 4.31B 29.47B 10.88B 97.5B 10.12B 9.92B 418B
Net Debt 4.38B 4.23B 4B 3.53B 6.27B 381B 6.99B 47.79B 17.64B 158B 16.42B 16.09B 678B 3.95B 3.81B 3.61B 3.18B 5.65B 343B 6.3B 43.1B 15.91B 143B 14.8B 14.51B 611B
More financial data * Estimated data
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Employees
14,100
More about the company
Date Price Change Volume
25-02-12 173.88 $ -0.24% 2,886,487
25-02-11 174.29 $ +1.38% 2,309,427
25-02-10 171.91 $ +0.28% 2,936,056
25-02-07 171.43 $ -1.54% 1,927,290
25-02-06 174.12 $ -0.88% 2,419,475

Delayed Quote Nyse, February 12, 2025 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
173.88USD
Average target price
208.60USD
Spread / Average Target
+19.97%
Consensus

Quarterly revenue - Rate of surprise